REDUCING PATIENT ACCESSIBILITY BARRIERS IN THE CLINICAL SETTING AND THE VALUE OF LIVED EXPERIENCE
With
Hannah McPierzie, Disability Consultant & Advocate &
Chair, Deafblind West Australians &
Non-Executive Director, Deafness Forum Australia
PEOPLE IN HEALTH CARE SEGMENT
Filmed in Perth | October 2025
Hannah McPierzie is a globally respected presenter, disability advocate, and educator who offers a unique perspective on disability and communication. She lives with Neurofibromatosis Type 2, a rare degenerative condition, and has two auditory brainstem implants. After 15 years teaching in the disability sector, Hannah acquired disability herself in 2020, when life-saving surgery left her deafblind.
Combining her professional expertise with lived experience, Hannah’s advocacy highlights the barriers people with disability face when navigating health systems, particularly in relation to communication access. She works with universities, hospitals, research institutes, private companies, and government agencies to build critical awareness of disability and to embed inclusive practices into policy and service design.
As Chairperson of Deafblind West Australians, Hannah has led initiatives that strengthen peer support and outreach for people with deafblindness. She is also a Non-Executive Director of Deafness Forum Australia, where she contributes to national advocacy on hearing loss. Her projects have included making advance care planning accessible for people with sensory loss, delivering community awareness training, and supporting the next generation of young leaders with disability.
Hannah is a keynote speaker at national and international conferences, where she champions the role of lived experience in health professions education and systemic reform. Her work consistently addresses the challenges of fragmented systems, inaccessible communication, and the need for genuine inclusion in decision-making. Based in Perth, Western Australia, Hannah continues to drive change that prioritises dignity, accessibility, and equity.
Source: Supplied
-
Australian Teletrial Program reaches significant milestones in trials and participants
Launched in 2022, the Australian Teletrial Program is an initiative designed to improve access to clinical trials for people living in regional and remote areas of Australia. It uses telemedicine and digital technologies to enable patients to participate in clinical trials without needing to travel long distances to major metropolitan centres, which can often be a barrier to participation for those in rural and isolated locations.
Recently Australian Health Journal met with Kaye Hewson, Director, Australian Teletrials Program, who spoke about the program’s recent achievements.
-
Global Women’s Health report identifies concerning drop in Australian breast cancer screening
The Hologic Global Women’s Health Index is one of the largest global reports dedicated exclusively to women’s health and wellbeing. Now in its fifth year, the Index tracks women’s health across five dimensions , Preventive Care, Emotional Health, Opinions of Health and Safety, Basic Needs and Individual Health – across 144 countries and territories, covering 97 per cent of the global adult population.
-
Awareness, diagnosis and treatment of Congenital Hypothyroidism
Australian Health Journal spoke to Associate Professor MIchelle Jack about congenital hypothyroidism and newborn screening and her concerns in the varying thresholds for across different states in Australia. Despite the existence of newborn screening programs since the 1970s, there is still controversy surrounding the appropriate screening levels. Congenital hypothyroidism, affecting about one in 3500 infants, can lead to severe intellectual and physical impairment if not diagnosed early. The condition is mainly caused by the thyroid gland’s failure to develop properly, resulting in insufficient thyroid hormone production.
